During the fourth CIIE, Songjiang Enterprise Shanghai Lechun Biotechnology Co., Ltd. signed a strategic cooperation agreement with DuPont, an innovator in the field of materials science.
According to the agreement, the two sides will give full play to their respective advantages, cooperate and complement each other, improve competitiveness, jointly develop the market, and ensure the product quality and delivery cycle of disposable consumables with high-level R&D capabilities and all-round technical support.
"The signing of this strategic cooperation agreement with DuPont indicates that the cooperation between Lechun Bio and DuPont in the field of biopharmaceuticals has reached a new level. In the future, in the rapidly developing application market areas such as disposable biotechnology solutions, the two sides will further strengthen cooperation to provide higher quality innovative materials to help the sustainable development of the biopharmaceutical industry. Le Chun Bio CEO Wang Feng said.
Xin Zhang, Business Director of Healthcare & Molykote® Specialty Lubrication Solutions Asia Pacific at DuPont Electronics & Industrial (e&i), said: "DuPont's strategic cooperation agreement with Lechun Biotech has taken a solid step to further help Chinese biopharmaceutical companies cope with the challenges of purity, reliability, safety and economy, and has also opened a new chapter in the long-term cooperation between the two companies in the field of biopharmaceuticals. ”
■ Reporter Liang Fengwen Provided by the interviewee
■ Text editor Yang Lu Xu Ping
■ Column Editor-in-Charge Li Xiang ■ Column Editor-in-Chief Zhang Jinzhou